ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 236 filers reported holding ABERDEEN STD GOLD ETF TR in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,999,470 | -6.9% | 226,086 | -3.3% | 0.02% | -11.8% |
| Q2 2023 | $4,293,666 | +270.4% | 233,732 | +280.4% | 0.02% | +240.0% |
| Q1 2023 | $1,159,316 | +9.0% | 61,437 | +0.9% | 0.01% | 0.0% |
| Q4 2022 | $1,063,574 | +8.6% | 60,880 | -1.0% | 0.01% | -16.7% |
| Q3 2022 | $979,000 | -8.1% | 61,500 | +0.1% | 0.01% | -14.3% |
| Q2 2022 | $1,065,000 | -6.7% | 61,465 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $1,142,000 | -3.1% | 61,465 | -8.5% | 0.01% | -12.5% |
| Q4 2021 | $1,179,000 | +15.0% | 67,153 | +10.4% | 0.01% | -11.1% |
| Q3 2021 | $1,025,000 | -0.9% | 60,845 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $1,034,000 | +562.8% | 60,845 | +540.5% | 0.01% | +400.0% |
| Q1 2021 | $156,000 | -10.3% | 9,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | -17.5% | 9,500 | -17.4% | 0.00% | -33.3% |
| Q3 2020 | $211,000 | +520.6% | 11,505 | +473.8% | 0.00% | +200.0% |
| Q2 2020 | $34,000 | – | 2,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudock, Inc. | 1,147,876 | $18,825,000 | 5.89% |
| UBP Investment Advisors SA | 716,194 | $11,750,000 | 4.80% |
| swisspartners Ltd. | 305,000 | $5,011,000 | 4.07% |
| Darwin Wealth Management, LLC | 1,380,786 | $22,644,000 | 3.95% |
| Cypress Capital, LLC | 527,505 | $8,651,000 | 3.53% |
| Newman Dignan & Sheerar, Inc. | 430,281 | $7,057,000 | 2.56% |
| SimpliFi, Inc. | 318,301 | $5,220,000 | 2.44% |
| Allen Capital Group, LLC | 577,017 | $9,463,000 | 2.08% |
| Almanack Investment Partners, LLC. | 1,191,188 | $19,536,000 | 1.99% |
| American Money Management, LLC | 314,165 | $5,152,000 | 1.92% |